The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

Size: px
Start display at page:

Download "The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care"

Transcription

1 The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Medical Retina November 2016 Association of Health Professions in Ophthalmology

2 General basic competences of non-medical eye health care professionals The basic skill set of an ophthalmic non-medical health care professional (qualified optometrist, orthoptist, ophthalmic nurse or ophthalmic clinical scientist) is to: Perform basic clinical ophthalmic assessment Follow protocols within their scope of practice under appropriate supervision Detect abnormalities through assessment and act on these findings Not make a diagnosis or treat This level of skills and competences is essential before undertaking further training and education for a Level 1 expanded role; and some HCPs may need additional ophthalmic training (basic ophthalmic training courses) to obtain these skills. Possession of a competence indicates demonstration of an understanding of the underlying principles, limitations and benefits of the skill, as well as being able to elicit the appropriate information accurately. History taking Basic science knowledge about symptomatology of eye disease Communication skills ability to elicit relevant information Clinical knowledge about ophthalmic presentations Ability to take a general ophthalmic history Ability to take a social, family and drug history Ability to take a relevant systemic history, including past medical history Ophthalmic examination Ophthalmic basic science knowledge - Anatomy - Physiology - Pathology - Optics - Microbiology Understanding of basic disease processes Ability to elicit and recognise the relevance of positive and negative findings on examination Visual acuity measurement understanding of various methods and notations External ocular examination Slit lamp examination Fundal examination Pupil reactions Eye movements Clinical assessment of visual fields Understand management of refractive error Investigations Recognise roles of various investigations and understand their basis Dealing with the needs of ophthalmic patients Understand the terminology and notation used for ophthalmic examinations including refractive status Communication skills - patients, relatives and colleagues - written, oral and non verbal Time management skills Patient as the focus of care Patient safety Infection control including equipment decontamination Knowledge of and adherence to local policies Team working Epidemiology of ophthalmic disease Understand basic drug principles Instil drops Administer drugs as prescribed Recognise allergies and common complications Teaching and education Recognise own development needs Ability to share basic information with patients for their education and understanding Personal development Self-learning Reflective practice Recognise and develop evidence based practice Recognise limitations of own practice and competences and works within this scope CPD identify channels through which skills can be maintained and developed 2

3 Competence in practice Medical Retina Relevant underlying knowledge in competence and behavioural skills. Level 1 Level 2 Level 3 Participate in screening, under supervision, of medical retina (MR) patients and participate in monitoring low risk patients with established diagnoses in protocol driven treatment clinics Participate in triage and assessment of new patients. Perform assessment, management and monitoring under specific protocols Participate in hospital based medical retina (MR) patient care, managing and discharging patients under the care of a consultant ophthalmologist Ophthalmic history taking An ability to Take a comprehensive history relevant to the patient with a medical retinal (MR) condition with particular emphasis on relevant past medical, ophthalmic and drug history Recognise specific systemic conditions of relevance to medical retinal (MR) diseases Elicit specific information in the differential diagnosis of MR and how the history may be helpful in determining the different conditions Recognise history relevant to systemic conditions which may affect medical retina treatment outcomes and refer to ophthalmologists as appropriate 3

4 Ophthalmic examination As per general competences Understand the anatomy, physiology and pathophysiology of the retina, with emphasis on the macula Understand and recognise the risk factors and differential diagnosis of disorders of retinal and macular pathology including : - AMD dry, and wet (neovascular) - Central retinal vein occlusion (CRVO) / branch retinal vein occlusion (BRVO) - Diabetic retinopathy / maculopathy - Cystoid macular oedema (CMO) - Central serous retinopathy (CSR) - Other differential diagnoses Detect and classify diabetic retinal disease Detect the features needed to accurately grade diabetic retinopathy Recognise and understand the relevance of anterior segment changes associated with medical retinal disease eg APD, rubeosis, anterior chamber activity Undertake a competent ophthalmic examination with regard to medical retinal disorders Use a 3 mirror fundus contact lens as indicated and interpret the results Detect the features needed to accurately grade diabetic retinopathy according to modified Early Treatment Diabetic Retinopathy Study (ETDRS) criteria including pre-proliferative retinopathy, diabetic maculopathy and PDR with high risk characteristics Investigations Perform OCT imaging and fundus photography Recognise basic pathology on OCT images and fundus photographs Understand diabetes, diabetic eye disease and its relevance to retinopathy screening Recognise the use of fluorescein and ICG angiography, and autofluorescence in medical retina service delivery Use and interpret of ICG Use and interpret OCT imaging software and fundus photographs to review data and make accurate diagnosis Select and interpret need for specific tests for medical retina conditions Recognise and use electrodiagnostics Recognise and use ultrasound 4

5 Investigations continued Understand the principles of fluorescein, ICG angiography and autofluorescence in medical retina service delivery Detect the features needed to accurately grade diabetic retinopathy Select and interpret need for specific tests for medical retina conditions Interpret fluorescein, ICG angiography and autofluorescence in medical retina service delivery Management and interventions Recognise acute retinal pathology, conduct appropriate tests and make appropriate referrals, clearly stating the level of urgency Recognise current national referral guidelines and detailed knowledge of local referral pathways for patients with medical retina disorders Understand the principles, processes and protocols of national diabetic retinopathy screening programmes Make re-treat decisions for namd within own level of competence, according to local protocols in a consultant ophthalmologist-led pathway, including the ability to determine when to seek further advice Recognise a disease course that is unusual Communicate with colleagues within a multidisciplinary setting Diagnose neovascular AMD (namd) with a provisional recommendation for treatment Differentially diagnose retinal and macular conditions and manage or refer as appropriate Make re-treat decisions for namd according to local protocols in a consultant ophthalmologist led pathway, including the ability to determine when further investigations are required in the event of atypical or suboptimal responses to treatment Monitor the response to treatment and modify management plan of referred patients Recognise risks and benefits of medical, laser and surgical interventions for different treatments for medical retina conditions Administer pharmacological interventions, including intravitreal injections in line with local policy and guidelines Integrate clinical data in order to make differential diagnoses, and instigate appropriate management plans according to protocol and supervision as required 5

6 Ability to deal with needs of ophthalmic patients Communicate to patients information about their diagnosis and potential management options including referral to rehabilitation services and eligibility for registration Provide information and psychological support for the patient and carers Recognise the risks for patients about the natural history of the condition and any therapeutic interventions Work in a team and communicate with relevant members Be aware of the rapidly evolving nature of medical retina treatments that may be requested by patients Be part of the consent pathway Communicate with patients about their diagnosis, treatment plans and outcomes Manage patients fears and concerns Understand pharmacology of anti-vegf medications, to include possible contraindications, side effects and drug interactions Administer pharmacological interventions in line with local policy and guidelines Teaching and education Inform and educate patients and carers regarding medical retina disorders and their management Inform/educate patients the reasons behind monitoring plan Teach and train other groups of professions 6

7 Personal development Direct self-learning Understand reflective practice Recognise the need to work within own level of competence Seek advice where appropriate Demonstrate participation in CPD Work within the clinical governance framework service Recognise NICE guidelines and local protocols for AMD, diabetic macular oedema (DMO) and RVOs Keep up to date with, apply and act upon the NICE guidelines and local protocols for AMD, diabetic macular oedema (DMO) and RVOs as part of the team Recognise clinical trials which may influence current and future practice Audit own and service activity Non-medical eye HPCs who participate in medical retina pathways must possess basic science knowledge of the epidemiology, clinical features, natural history and possible progression of the various types of disease. They will be familiar with evidence based guidelines and have a knowledge of basic principles and limitations of relevant equipment and tests along with the technical skills to employ it effectively. The Level 1 competences are in keeping with the Professional Certificate in medical retina currently available from the University of Cardiff, City University of London and Ulster University. 7

8 Abbreviations AMD Age Related Macular Degeneration ICG Indocyanine Green APD Afferent Pupillary Defect IOP Intra Ocular Pressure BRVO Branch Retinal Vein Occlusion IP Independent Prescriber CMO Cystoid Macular Oedema LA/GA Local Anaesthetic/General Anaesthetic COAG Chronic Open Angle Glaucoma MR Medical Retina CPD CRVO CSR DM DMO DR HCPs HEIs Continuing Professional Development Central Retinal Vein Occlusion Central Serous Retinopathy Diabetes Mellitus Diabetic Macular Oedema Diabetic Retinopathy Health Care Professionals Higher Education Institutions namd OCT OHT PGD PI RVO SLT Neovascular Age Related Macular Degeneration (wet AMD) Optical Coherence Tomography Ocular Hypertension Patient Group Directive Peripheal Iridotomy Retinal Vein Occlusion Selective Laser Trabeculoplasty HES Hospital Eye Service Contact Professor Caroline MacEwen President The Royal College of Ophthalmologists 18 Stephenson Way London NW1 2HD T E.

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Cataract November 2016 Association of Health Professions in Ophthalmology General basic competences

More information

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Acute & Emergency Care November 2016 Association of Health Professions in Ophthalmology General

More information

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Glaucoma November 2016 Association of Health Professions in Ophthalmology General basic competences

More information

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina Learning outcomes for the Professional Certificate in Medical Retina, incorporating diabetic retinopathy screening and age related macular degeneration The professional certificate is a prerequisite to

More information

School of Health Sciences Department or equivalent Division of Optometry and Visual Science UK credits 15 ECTS 7.5 Level 7

School of Health Sciences Department or equivalent Division of Optometry and Visual Science UK credits 15 ECTS 7.5 Level 7 MODULE SPECIFICATION KEY FACTS Module name Medical Retina Module code OVM056 School School of Health Sciences Department or equivalent Division of Optometry and Visual Science UK credits 15 ECTS 7.5 Level

More information

Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO)

Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO) Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England (Royal Victoria Infirmary, Sunderland Eye Infirmary, James Cook University Hospital, Darlington Memorial Hospital, University Hospital

More information

Ophthalmology Unit Referral Guidelines

Ophthalmology Unit Referral Guidelines Ophthalmology Unit Referral Guidelines Austin Health Ophthalmology Unit holds sub-specialty sessions to discuss and plan the treatment of patients with specific ocular conditions. General including cataract

More information

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA OCCLUSIVE VASCULAR DISORDERS OF THE RETINA Learning outcomes By the end of this lecture the students would be able to Classify occlusive vascular disorders (OVD) of the retina. Correlate the clinical features

More information

DIABETIC RETINOPATHY

DIABETIC RETINOPATHY THE UK GUIDE DIABETIC RETINOPATHY Everything you need to know about diabetic retinopathy Jaheed Khan BSc (Hons) MBBS MD FRCOphth Fellow of the Royal College of Ophthalmologists Association for Research

More information

Ophthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description

Ophthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Ophthalmic VEGF Inhibitors Page: 1 of 5 Last Review Date: September 20, 2018 Ophthalmic VEGF Inhibitors

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema. NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health Technology Appraisal Aflibercept for treating diabetic macular oedema Final scope Final remit/appraisal objective To appraise the clinical and cost

More information

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening linical Guidelines Hydroxychloroquine and hloroquine Retinopathy: Recommendations on Screening February 2018 - Review date: February 2021 Executive Summary Recent data have highlighted that hydroxychloroquine

More information

Perspectives on Screening for Diabetic Retinopathy. Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal

Perspectives on Screening for Diabetic Retinopathy. Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal Perspectives on Screening for Diabetic Retinopathy 1 Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal Current standards 2 According to the Canadian Diabetes

More information

04/11/2014. Retina Coding and Reimbursement 101. Financial Disclosure. Chief Complaint

04/11/2014. Retina Coding and Reimbursement 101. Financial Disclosure. Chief Complaint Retina Coding and Reimbursement 101 William T. Koch, COA, COE, CPC Administrative Director Director of Billing Operations The Retina Institute St. Louis, Missouri Advisory Boards Allergan Genentech Regeneron

More information

Information for patients

Information for patients Information for patients Intravitreal Anti-VEGF Treatment (vascular endothelial growth factor) This leaflet gives you information that will help you decide whether to have intravitreal treatment. It also

More information

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features

More information

Ophthalmology Macular Pathways

Ophthalmology Macular Pathways Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological

More information

Syllabus-Ophthalmology Rotation Course: Objectives & Goals LOYOLA UNIVERSITY CHICAGO STRITCH SCHOOL OF MEDICINE

Syllabus-Ophthalmology Rotation Course: Objectives & Goals LOYOLA UNIVERSITY CHICAGO STRITCH SCHOOL OF MEDICINE Syllabus-Ophthalmology Rotation Course: Objectives & Goals LOYOLA UNIVERSITY CHICAGO STRITCH SCHOOL OF MEDICINE Department of Ophthalmology Course Objectives: By Core Competencies GENERAL INFORMATION:

More information

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist Serious Eye diseases, New treatments Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist 5 major causes of loss of vision Cataracts Glaucoma Macular degeneration Retinal Vein occlusions

More information

GENERAL INFORMATION DIABETIC EYE DISEASE

GENERAL INFORMATION DIABETIC EYE DISEASE GENERAL INFORMATION DIABETIC EYE DISEASE WHAT IS DIABETIC EYE DISEASE? Diabetic eye disease is a term used to describe the common eye complications seen in people with diabetes. It includes: Diabetic retinopathy

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment

More information

04/06/2015. Documentation Do s and Don ts In The Retina Practice. Financial Disclosure. Documentation Dos and Don ts

04/06/2015. Documentation Do s and Don ts In The Retina Practice. Financial Disclosure. Documentation Dos and Don ts Documentation Do s and Don ts In The Retina Practice William T. Koch, COA, COE, CPC Administrative Director Director of Billing Operations The Retina Institute St. Louis, Missouri Advisory Boards Allergan

More information

Research Article http://www.alliedacademies.org/clinical-ophthalmology-and-vision-science/ A 2-year retrospective study of the treatment of retinal vein occlusion with dexamethasone 0.7 mg intravitreal

More information

Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series

Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series Joseph J. Pizzimenti, OD, FAAO Associate Professor Nova Southeastern University The Eye Care Institute pizzimen@nova.edu

More information

Hong Kong College of Surgical Nursing

Hong Kong College of Surgical Nursing Hong Kong College of Surgical Nursing Surgical Nursing Training: Part B Specialty - Ophthalmological Nursing Curriculum 1 TABLE OF CONTENTS No. Contents Page 1. Introduction 3 2. Aims 3 3. Programme Intended

More information

Case Follow Up. Sepi Jooniani PGY-1

Case Follow Up. Sepi Jooniani PGY-1 Case Follow Up Sepi Jooniani PGY-1 Triage 54 year old M Pt presents to prelim states noticed today he had reddness to eyes, states worse in R eye. Pt denies any pain or itching. No further complaints.

More information

OPHTHALMOLOGY DEPARTMENT Primary care referral guidelines

OPHTHALMOLOGY DEPARTMENT Primary care referral guidelines OPHTHALMOLOGY DEPARTMENT Primary care referral guidelines Contents REFERRAL CATEGIES... 2 Emergency... 2 Urgent... 2 Semi urgent/routine... 2 Not accepted... 2 OPHTHALMOLOGY CONDITIONS NOT ACCEPTED...

More information

Clinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital

Clinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital Clinical Case Presentation on Branch Retinal Vein Occlusion Sarita M. Registered Nurse Whangarei Base Hospital Introduction Case Study Pathogenesis Clinical Features Investigations Treatment Follow-up

More information

Manual. Manual Welsh Eye Care Initiative. A Welsh Eye Care Initiative. Protocol. The Assessment and Management of Age-related Macular Degeneration

Manual. Manual Welsh Eye Care Initiative. A Welsh Eye Care Initiative. Protocol. The Assessment and Management of Age-related Macular Degeneration A Protocol 1.0 Definitions The following terms are important in this text: Wet Macular Degeneration Condition caused by the growth of abnormal blood vessels under the retina. Symptoms appear suddenly and

More information

Eye injection treatment costs and rebates

Eye injection treatment costs and rebates Eye injection treatment costs and rebates This fact sheet provides general information on the bill you receive from your ophthalmologist for eye injections for the management of wet macular degeneration,

More information

Treatment of Retinal Vein Occlusion (RVO)

Treatment of Retinal Vein Occlusion (RVO) Manchester Royal Eye Hospital Medical Retina Services Information for Patients Treatment of Retinal Vein Occlusion (RVO) What is a Retinal Vein Occlusion (RVO)? The retina is the light sensitive layer

More information

Eye injection treatment costs and rebates

Eye injection treatment costs and rebates Eye injection treatment costs and rebates This fact sheet provides general information on the bill you receive from your ophthalmologist for eye injections for the management of wet macular degeneration,

More information

Examining the Eyes. Mr. Nicholas Lee Lead Clinician Consultant Ophthalmologist at Hillingdon and The Western Eye Hospitals

Examining the Eyes. Mr. Nicholas Lee Lead Clinician Consultant Ophthalmologist at Hillingdon and The Western Eye Hospitals Examining the Eyes Mr. Nicholas Lee Lead Clinician Consultant Ophthalmologist at Hillingdon and The Western Eye Hospitals Ophthalmology - Eyes Ophthalmology Medical - Busiest outpatient department Glaucoma

More information

Mild NPDR. Moderate NPDR. Severe NPDR

Mild NPDR. Moderate NPDR. Severe NPDR Diabetic retinopathy Diabetic retinopathy is the most common cause of blindness in adults aged 35-65 years-old. Hyperglycaemia is thought to cause increased retinal blood flow and abnormal metabolism in

More information

and at the same patient encounter. Code has been deleted. For scanning computerized ophthalmic diagnostic imaging of optic nerve and retin

and at the same patient encounter. Code has been deleted. For scanning computerized ophthalmic diagnostic imaging of optic nerve and retin 92227: Remote imaging for detection of retinal disease (eg, retinopathy in a patient with diabetes) with analysis and report under physician supervision, unilateral or bilateral. For Medicare, bill only

More information

OPHTHALMOLOGICAL DISORDERS

OPHTHALMOLOGICAL DISORDERS Telephone No.: 24622495 Telegraphic Address: Aeronautical: VIDDYAYX Commercial: AIRCIVIL NEW DELHI E Mail: dri@dgca.nic.in Fax:01124629211 GOVERNMENT OF INDIA AERONAUTICAL INFORMATION SERVICE DIRECTOR

More information

RETINAL CONDITIONS RETINAL CONDITIONS

RETINAL CONDITIONS RETINAL CONDITIONS GENERAL INFORMATION RETINAL CONDITIONS RETINAL CONDITIONS WHAT ARE RETINAL CONDITIONS? Retinal conditions affect the light-sensitive tissue at the back of eye known as the retina. They include diseases

More information

Speaker Disclosure Statement. " Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose.

Speaker Disclosure Statement.  Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose. Speaker Disclosure Statement Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose. Diabetes Morbidity Diabetes doubles the risk of stroke. Diabetes quadruples the risk of

More information

Glaucoma: diagnosis and management (large print version)

Glaucoma: diagnosis and management (large print version) Glaucoma: diagnosis and management (large print version) 1 November 2017 Recommendations People have the right to be involved in discussions and make informed decisions about their care, as described in

More information

A Patient s Guide to Diabetic Retinopathy

A Patient s Guide to Diabetic Retinopathy Diabetic Retinopathy A Patient s Guide to Diabetic Retinopathy 840 Walnut Street, Philadelphia PA 19107 www.willseye.org Diabetic Retinopathy 1. Definition Diabetic retinopathy is a complication of diabetes

More information

Chronic eye diseases. Title of section divider. What s new, and how GPs can help. Eg. Case Study 1. Dr Jesse Gale, ophthalmologist

Chronic eye diseases. Title of section divider. What s new, and how GPs can help. Eg. Case Study 1. Dr Jesse Gale, ophthalmologist Chronic eye diseases Title of section divider What s new, and how GPs can help Eg. Case Study 1. Dr Jesse Gale, ophthalmologist 1 Title of section divider Cataract Eg. Case Study 1. 2 Cataract - what s

More information

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing

More information

Clinically Significant Macular Edema (CSME)

Clinically Significant Macular Edema (CSME) Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2

More information

Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema

Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema V Swetha E Jeganathan 1,2 * and Karen Madill 3 1 Department of Ophthalmology,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension 1.1 Short title Glaucoma 2 Background

More information

The Human Eye. Cornea Iris. Pupil. Lens. Retina

The Human Eye. Cornea Iris. Pupil. Lens. Retina The Retina Thin layer of light-sensitive tissue at the back of the eye (the film of the camera). Light rays are focused on the retina then transmitted to the brain. The macula is the very small area in

More information

GLAUCOMA REPEAT READINGS PATHWAY

GLAUCOMA REPEAT READINGS PATHWAY GLAUCOMA REPEAT READINGS PATHWAY Level 1a: Goldmann style applanation tonometry repeat readings A first level community service for IOP refinement where other signs of glaucoma are not present will reduce

More information

The Future of Optometric Services in Primary Care in Wales

The Future of Optometric Services in Primary Care in Wales IMPROVING HEALTH IN WALES The Future of Optometric Services in Primary Care in Wales a consultation document ISBN 0 7504 2968 2 Designed by CartoGraphic Services G/254/02-03 September 2002 INA - 15-02

More information

aflibercept 40mg/mL solution for injection (Eylea ) SMC No. (1074/15) Bayer

aflibercept 40mg/mL solution for injection (Eylea ) SMC No. (1074/15) Bayer aflibercept 40mg/mL solution for injection (Eylea ) SMC No. (1074/15) Bayer 07 August 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards

More information

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014 From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014 1. This course is designed to review the important ophthalmic literature that was released between October 2013

More information

FRANZCO, MD, MBBS. Royal Darwin Hospital

FRANZCO, MD, MBBS. Royal Darwin Hospital Diabetes and Eye By Dr. Nishantha Wijesinghe FRANZCO, MD, MBBS Consultant Ophthalmologist Royal Darwin Hospital 98% of Diabetics do not need to suffer from severe visual loss Yet Diabetic eye disease is

More information

Appendix M: Expert witness testimonial

Appendix M: Expert witness testimonial M.1 Heading of question Review question RQ5: How do different organisational models and referral pathways for triage, diagnosis, ongoing treatment and follow up influence outcomes for people with suspected

More information

Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection

Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection Information for Patients Manchester Royal Eye Hospital Medical Retina Services Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection What is age related macular degeneration (AMD)?

More information

NEW YORK UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF OPHTHALMOLOGY EDUCATIONAL OBJECTIVES AND GOALS

NEW YORK UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF OPHTHALMOLOGY EDUCATIONAL OBJECTIVES AND GOALS NEW YORK UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF OPHTHALMOLOGY EDUCATIONAL OBJECTIVES AND GOALS Revision Date: 6/30/06 Distribution Date: 7/6/06 The Department of Ophthalmology at the NYU Medical Center

More information

Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA

Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA Vision 2020 Australia Vision Initiative RANZCO & OAA (Vic) Proud members of Vision 2020 Australia Outline Vision

More information

10/17/2017. FDA Approved. Zeiss AngioPlex TM Optovue AngioVue TM

10/17/2017. FDA Approved. Zeiss AngioPlex TM Optovue AngioVue TM Images retinal microvasculature without dye injection Displays structure and function from a single imaging system Standard of Care-2011 DFE, Fundus Photos, VF 10-2, SD-OCT, FAF, or mferg 2016-AAO Baseline

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and social care directorate Quality standards and indicators Briefing paper

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and social care directorate Quality standards and indicators Briefing paper NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and social care directorate Quality standards and indicators Briefing paper Quality standard topic: Serious eye disorders Output: Prioritised quality

More information

NICE guideline Published: 1 November 2017 nice.org.uk/guidance/ng81

NICE guideline Published: 1 November 2017 nice.org.uk/guidance/ng81 Glaucoma: diagnosis and management NICE guideline Published: 1 November 2017 nice.org.uk/guidance/ng81 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

www.brisbaneeyeclinic.com.au Brisbane Eye Clinic is a modern ophthalmology practice focused on the provision of excellent medical eye care. The Clinic has two convenient consulting locations, our Wickham

More information

Role of Fluorescein angiography in evaluation of posterior segment disorders

Role of Fluorescein angiography in evaluation of posterior segment disorders Original Article Role of Fluorescein angiography in evaluation of posterior segment disorders Arvind R, Surendar S 2, Ch. Jagan Mohan Rao 3 Associate Professor, 2 Postgraduate student, 3 Senior resident,

More information

ILUVIEN IN DIABETIC MACULAR ODEMA

ILUVIEN IN DIABETIC MACULAR ODEMA 1 ILUVIEN IN DIABETIC MACULAR ODEMA Marie Tsaloumas Consultant Ophthalmic Surgeon Queen Elizabeth Hospital, Birmingham bars conference 2104 1 2 Declaration of interest I have sat on Advisory boards for

More information

CENTRAL MERSEY LOCAL OPTICAL COMMITTEE

CENTRAL MERSEY LOCAL OPTICAL COMMITTEE CENTRAL MERSEY LOCAL OPTICAL COMMITTEE OPTOMETRIC REFERRAL GUIDELINES The ocular conditions listed in this document are intended to reflect those that might be encountered in optometric practice and this

More information

Sponsored by. Shared care and referral pathways. Part 2: diabetes screening leading from the front

Sponsored by. Shared care and referral pathways. Part 2: diabetes screening leading from the front CET CONTINUING Sponsored by 1 CET POINT Shared care and referral pathways Part 2: diabetes screening leading from the front Chris Steele, BSc (Hons), FCOptom, DCLP, DipOC, DipTp(IP), FBCLA The alarming

More information

measure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

PRESCRIBING IN GLAUCOMA: GUIDELINES FOR NZ OPTOMETRISTS

PRESCRIBING IN GLAUCOMA: GUIDELINES FOR NZ OPTOMETRISTS PRESCRIBING IN GLAUCOMA: GUIDELINES FOR NZ OPTOMETRISTS Introduction Independent prescribing relates to the capacity to use clinical judgement in respect of diagnosis and treatment. It does not mean working

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and social care directorate Quality standards and indicators Briefing paper

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and social care directorate Quality standards and indicators Briefing paper NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and social care directorate Quality standards and indicators Briefing paper Quality standard topic: Serious eye disorders Output: Prioritised areas

More information

The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado

The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado Tentative 1/23/17 PROGRAM MONDAY, MARCH 13, 2017 Morning Session 6:00-7:00 Registration

More information

Dr. Harvey Richman, OD, FAAO, FCOVD Diplomate American Board of Optometry Executive Committee AOA Third Party Center Founder Ask the AOA Coding

Dr. Harvey Richman, OD, FAAO, FCOVD Diplomate American Board of Optometry Executive Committee AOA Third Party Center Founder Ask the AOA Coding Dr. Harvey Richman, OD, FAAO, FCOVD Diplomate American Board of Optometry Executive Committee AOA Third Party Center Founder Ask the AOA Coding Experts 92000 Codes Special Ophthalmological Services Describe

More information

Diabetic Retinopathy Screening Program in the Cree Region of James Bay of Quebec

Diabetic Retinopathy Screening Program in the Cree Region of James Bay of Quebec RUIS McGILL VIRTUAL HEALTH AND SOCIAL SERVICES CENTRE (CvSSS) SIMPLIFYING TELEHEALTH! Diabetic Retinopathy Screening Program in the Cree Region of James Bay of Quebec Nurse and Imager Training Prepared

More information

The Trust does not record electronically the number of patients who are treated by laser for a condition.

The Trust does not record electronically the number of patients who are treated by laser for a condition. Ref: FOI/CAD/ID 3224 06 April 20 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act 2000

More information

Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and

Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and British Journal of Ophthalmology, 1977, 61, 278-284 Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma LEILA LAATIKAINEN From Moorfields Eye Hospital,

More information

LOCSU/WOPEC Courses to support the development of local enhanced eye care services. Excellence in Education for Eye Care Professionals

LOCSU/WOPEC Courses to support the development of local enhanced eye care services. Excellence in Education for Eye Care Professionals LOCSU/WOPEC Courses to support the development of local enhanced eye care services Excellence in Education for Eye Care Professionals LOCSU/WOPEC training courses are designed to support the delivery of

More information

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May BRAND NAME Lucentis GENERIC NAME ranibizumab MANUFACTURER Genentech, Inc. DATE OF APPROVAL June 30, 2006 PRODUCT LAUNCH DATE July 13, 2006 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review of

More information

When optical coherence tomography (OCT)

When optical coherence tomography (OCT) Macular Imaging: SD-OCT in nterior Segment Surgical Practice Many pathologic processes of the macula can be visualized or quantified only with this modality. y Steven G. Safran, MD When optical coherence

More information

For further reading we recommend the following excellent textbooks:

For further reading we recommend the following excellent textbooks: FURTHER READING Intravitreal Injections Downloaded from www.worldscientific.com For further reading we recommend the following excellent textbooks: Clinical Anatomy of the Eye by Richard S Snell and Michael

More information

Multidisciplinary Glaucoma Service Design. Paul GD Spry PhD MCOptom DipGlau DipTp(IP) Head of Optometry, Bristol Eye Hospital

Multidisciplinary Glaucoma Service Design. Paul GD Spry PhD MCOptom DipGlau DipTp(IP) Head of Optometry, Bristol Eye Hospital Multidisciplinary Glaucoma Service Design Paul GD Spry PhD MCOptom DipGlau DipTp(IP) Head of Optometry, Bristol Eye Hospital 1. HES Optometrist Consultant 2. Text book co-author Spry and Harper, Essential

More information

Improving Eye Health. Cardiff and Vale University Health Board

Improving Eye Health. Cardiff and Vale University Health Board Improving Eye Health Cardiff and Vale University Health Board Local Eye Care Plan 2013-2018 1. Introduction On the 18 th September 2013 the Welsh Government published Together for Health: Eye Health Care,

More information

LOCSU Community Services. Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway. Issued by Local Optical Committee Support Unit May 2009

LOCSU Community Services. Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway. Issued by Local Optical Committee Support Unit May 2009 LOCSU Community Services Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway Issued by Local Optical Committee Support Unit May 2009 [Revised November 2013] Contents Page Executive Summary...

More information

Macular edema (ME) is the most common

Macular edema (ME) is the most common MANAGEMENT OF RETINAL VEIN OCCLUSIONS * Peter A. Campochiaro, MD ABSTRACT Macular edema (ME) is the most common cause of reduced vision in patients with retinal vein occlusions (RVOs). The primary cause

More information

Ophthalmologic Policy. Vascular Endothelial Growth Factor (VEGF) Inhibitors

Ophthalmologic Policy. Vascular Endothelial Growth Factor (VEGF) Inhibitors Ophthalmologic Policy UnitedHealthcare Commercial Drug Policy Vascular Endothelial Growth Factor (VEGF) Inhibitors Policy Number: 2016D0042H Effective Date: October 1, 2016 Table of Contents Page INSTRUCTIONS

More information

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

ZEISS AngioPlex OCT Angiography. Clinical Case Reports Clinical Case Reports Proliferative Diabetic Retinopathy (PDR) Case Report 969 PROLIFERATIVE DIABETIC RETINOPATHY 1 1-year-old diabetic female presents for follow-up of proliferative diabetic retinopathy

More information

SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES

SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES TABLE OF CONTENTS Summary Benchmarks for Preferred Practice Pattern Guidelines Introduction... 1 Glaucoma Primary Open-Angle Glaucoma (Initial

More information

Updates to the Alberta Drug Benefit List. Effective August 1, 2017

Updates to the Alberta Drug Benefit List. Effective August 1, 2017 Updates to the Alberta Drug Benefit List Effective August 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

SCIENTIFIC PROGRAM. Pediatric ophthalmology- Optometry challenges (max 20 attendees)

SCIENTIFIC PROGRAM. Pediatric ophthalmology- Optometry challenges (max 20 attendees) FRIDAY, 22 SEPTEMBER 2017 WORKSHOPS (OPHTHALMICA Eye Institute) 08:30-09:00 Registration-Welcome 09:00-11:30 Workshops SCIENTIFIC PROGRAM I. Cornea & Refractive surgery (max 30 attendees) - Clinical examination

More information

There are no published randomized, double-blind trials comparing aflibercept to other therapies in neovascular AMD.

There are no published randomized, double-blind trials comparing aflibercept to other therapies in neovascular AMD. Subject: Eylea (aflibercept) Original Effective Date: 7/11/2014 Policy Number: MCP-191 Revision Date(s): 10/11/2016 Review Date(s): 12/16/2015; 10/11/2016, 6/22/2017, 7/10/2018 DISCLAIMER This Medical

More information

Diabetic Retinopathy A Presentation for the Public

Diabetic Retinopathy A Presentation for the Public Diabetic Retinopathy A Presentation for the Public Ray M. Balyeat, MD The Eye Institute Tulsa, Oklahoma The Healthy Eye Light rays enter the eye through the cornea, pupil and lens. These light rays are

More information

PRODUCTION ANIMAL AND EQUINE OPHTHALMOLOGY

PRODUCTION ANIMAL AND EQUINE OPHTHALMOLOGY REF. NO. TITLE: C-VO.2 PRODUCTION ANIMAL AND EQUINE OPHTHALMOLOGY VALUE: 10 CREDITS NOTIONAL STUDY HOURS: 100 This module is intended to cover the theoretical knowledge of both Production Animal and Equine

More information

Ophthalmology. Caring For Your Eyes. Jurong Medical Centre

Ophthalmology. Caring For Your Eyes. Jurong Medical Centre Ophthalmology Caring For Your Eyes Jurong Medical Centre Your eyes and you At Jurong Medical Centre, we have a dedicated team of ophthalmologists that specialise in treating a wide range of acute and chronic

More information

Retinal vein occlusion (RVO) is a vascular disease

Retinal vein occlusion (RVO) is a vascular disease INTRAVITREAL RANIBIZUMAB FOR RETINAL VEIN OCCLUSION THROUGH 1 YEAR IN CLINICAL PRACTICE TROELS BRYNSKOV, MD,* HENRIK KEMP, MD,* TORBEN L. SØRENSEN, MD, DMSC* Purpose: To evaluate the efficacy and safety

More information

Diabetic Retinopathy

Diabetic Retinopathy Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.

More information

Commissioning Guide: Glaucoma (Long Version)

Commissioning Guide: Glaucoma (Long Version) Draft for Consultation Commissioning Guide: Glaucoma (Long Version) March 2015 Contents Section page 1. ABBREVIATIONS 4 2. Introduction: Glaucoma 5 3. Commissioning Guidance for Glaucoma 7 4. HIGH VALUE

More information

Will OCT-Angiography replace FA?

Will OCT-Angiography replace FA? ASL Roma A PRESIDIO TERRITORIALE NUOVO REGINA MARGHERITA AMBULATORIO PATOLOGIE RETINICHE Resp. Dott.ssa SUSANNA CATALANO CENTRO ITALIANO MACULA Will OCT-Angiography replace FA? Marco Rispoli, Luca di Antonio,

More information

DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES

DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES October 2013 Preoperative assessment History Symptoms/social history: is the patient visually affected and do they want

More information

www.brisbaneeyeclinic.com.au Brisbane Eye Clinic is a modern ophthalmology practice focused on the provision of excellent medical eye care. The Clinic has two convenient consulting locations, our Wickham

More information

Enhanced Scheme Evaluation Project (ESEP) Robert Harper On behalf of the ESEP team

Enhanced Scheme Evaluation Project (ESEP) Robert Harper On behalf of the ESEP team Enhanced Scheme Evaluation Project (ESEP) Robert Harper On behalf of the ESEP team ESEP Team Project Leads: Robert Harper and John Lawrenson Co-applicants: David Edgar, Cecilia Fenerty, David Henson, Ian

More information

JINNAH SINDH MEDICAL UNIVERSITY STUDY GUIDE- OPHTHALMOLOGY YEAR 4,

JINNAH SINDH MEDICAL UNIVERSITY STUDY GUIDE- OPHTHALMOLOGY YEAR 4, INTRODUCTION Pakistan, the 7th most populous country in the world, has an urban population of 38.8% and rural dwellers of 61.2%. The country has faced challenges with vision impairment and blindness as

More information

OPHTHALMOLOGIC POLICY: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS

OPHTHALMOLOGIC POLICY: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS UnitedHealthcare Commercial Medical Benefit Drug Policy OPHTHALMOLOGIC POLICY: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS Policy Number: PHA020 Effective Date: September 1, 2018 Table of Contents

More information

Photodynamic Therapy (PDT) for agerelated

Photodynamic Therapy (PDT) for agerelated Page 1 of 5 Photodynamic Therapy (PDT) for agerelated eye conditions Introduction This leaflet gives you information about Photodynamic Therapy (PDT) for the age--related eye conditions macular degeneration

More information

EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY

EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY Diwakar chaudhary *1, 2, Hu shuqiong, Long Yuan and Xiong kun 1 Yangtze University, 1 Nanhuan Road

More information